Company Filing History:
Years Active: 2003-2012
Title: The Innovations of Patrice Mauriac
Introduction
Patrice Mauriac is a notable inventor based in Paris, France. He has made significant contributions to the field of biomedical engineering, particularly in the development of subcutaneous implants. With a total of 2 patents, his work focuses on enhancing the efficacy and safety of drug delivery systems.
Latest Patents
Mauriac's latest patents include innovative methods for preparing subcutaneous implants. One patent details the use of ethanol as a plasticizer for creating implants that contain thermolabile active principles dispersed in a PLGA matrix. This method allows for the preparation of a plasticized polymer of PLGA at a temperature that is higher than the glass transition temperature (Tg) but lower than the boiling point of ethanol. The result is a versatile implant that can effectively deliver active ingredients. Another patent involves compositions that combine a peptide with polylactic-glycolic acid (PLGA). This composition is designed to create subcutaneous implants with an extended release period, ensuring that the release time is at least six months.
Career Highlights
Throughout his career, Mauriac has worked with various companies, including Mediolanum Farmaceutici S.p.a. and Mediolanum Pharmaceuticals Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical formulations and implant technologies.
Collaborations
Mauriac has collaborated with several professionals in his field, including Pierre Marion and Alain Maquin. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Patrice Mauriac's contributions to the field of biomedical engineering through his innovative patents demonstrate his commitment to improving drug delivery systems. His work continues to influence the development of effective subcutaneous implants, showcasing the importance of innovation in healthcare.